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Folded polymers are utilized in virtually all vital processes in
nature. Non-natural folded polymers (foldamers) have the
potential for being similarly or even more versatile, and the
design of such molecules is of considerable current interest.[1]
In this respect, b- and chimera ab-peptides are perhaps the
best characterized foldamers,[2] as they form a number of
residue-controlled secondary structures, which have been
used for various biological applications[3] and to create
nanostructured materials.[4] The folding procedure is influ-
enced by many factors, such as the residue type, the side-chain
topology and chemistry, the pattern of hydrophobic regions
along the backbone, the solvent, etc.[5] For peptidic foldamers,
the backbone stereochemistry plays a key role in the
formation of the secondary structure.[6] For b-peptides
correlations have been revealed between the stereochemistry
of the residues and the secondary structure: a change in the
relative stereochemistry within the b residues effectively
changes the secondary structure, which can be either a helix
or a strand.[7] For a-peptides, a systematic tuning of the
secondary structure is also possible by using a specific
stereochemical pattern (e.g., dl-a-amino acid stabilized
b helix and a strand).[5c–e,8] The use of stereochemical pattern-
ing along the backbone and simultaneous variation of the
residue types (a and b residues) can lead to novel periodic
secondary structures. Herein we show that the stereochemical
patterning yields a simple, intuitive foldamer design tool and
furnishes a highly effective de novo construction method-
ology for generating peptidic foldamers having tailored
properties and potential biological activities.
The effects of the stereochemistry of the residues on the
overall geometry of the peptide are conveyed through the
local torsional preferences and the side chain–backbone
interactions.[2] Therefore, the torsional requirements within
the peptide backbone for various H-bond-stabilized periodic
secondary structures[1,3,6–12] were studied first. The f and y
torsions were analyzed according to the Ramachandran[13]
and Balaram[14] definitions for the a and b residues, respec-
tively. Although the b residues contain an additional dihedral
angle q(N-Cb-Ca-CO), q is dependent on f and y, and its
gauche conformation is inherently stable, as demonstrated by
thorough analyses.[15]
The dihedral angle pattern for the repeating units
revealed that the signs of the torsions flanking the amide
moiety (y][f, where ][ designates the CONH group) are
crucial with respect to the type of induced secondary
structure, and the signs also determine the orientation of
amides within the helices. The observed rules are summarized
in Table 1 (for the original data utilized for this analysis see
Table S1 in the Supporting Information).
Since a helix (by definition) has a fixed overall helicity
along a sequence, and it requires stabilizing hydrogen bonds
between identically oriented amide moieties at periodic
distances, the sequence of the y][f signs must also exhibit a
periodic pattern. If a helix is stabilized by ii+n peptide
bond contacts, then the y][f pattern starting from position i
should be identical to that starting at i+ n. The homochiral
helices having uniformly oriented amides, and the alternating
heterochiral helices having alternating amide orientations are
special cases of the class of periodic y][f sign sequences.
The stereochemistry of the polypeptide chain[2,13] reveals a
correlation between the signs of the torsions and the absolute
configurations of the residues (Table 2). This correlation was
established by replacing side-chain groups with a methyl
group to retain the CIP (Cahn–Ingold–Prelog) designation
for identical spatial arrangements. Structures of the peptidic
Table 1: The secondary structure preference of the y][f building blocks.
Signs of y][f Secondary
structure
Amide orientation in
P and M helices[a]
+][+ helix P: parallel; M: antiparallel
][ helix P: antiparallel; M: parallel
+][ strand
][+ strand
[a] NH to O=C H-bond orientations relative to the N-terminal to C-
terminal direction. P= right-handed helix, M= left-handed helix.
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sequences containing unsubstituted or a,a-dialkyl-substituted
residues suggests that the adjacent torsion angles tend to
accommodate helix formation.[16,17]
To test the predictive ability of the above relationships in a
de novo helix design, y][f sequences and the corresponding
stereochemical patterns were assembled (1–3, Figure 1).
Sequences for 4–6 were designed to disrupt the like junctions
and the periodic y][f patterns in the central region.
Stereochemical patterning was used for the whole sequence,
and the designed sequences were compiled into real b- and
ab-peptides by using ACPC (ACPC= cis-2-aminocyclopen-
tanecarboxylic acid) diastereomers, b3-amino acids, and a-
amino acid enantiomers having the appropriate absolute
configurations. The side-chain stereochemistry was chosen so
as to permit advantageous interactions between the juxta-
posed residues and to introduce biomimetic proteinogenic
side chains.
A hybrid Monte Carlo (MC)/molecular dynamics (MD)
conformational search was carried out through molecular
mechanics[18] without using any distance restraints. The
resulting families having the lowest-energy conformations
for 1–3 indicated helical conformations. For 4–6, meandering
backbone geometry derived from turn-like segments was
detected in the low-energy conformations, which lacked any
long-range order. The lowest-energy conformers from the
simulations of 1–3 were additionally optimized at the ab initio
quantum chemical level of theory. The structure optimiza-
tions converged properly, and novel foldameric helices were
found. For 1 and 2, the left-handed (M) helix is stabilized by
concatenated 14- and 16-membered H-bonded pseudorings
(H14-16, Figure 2a), whereas 2 exhibits a potential salt-bridge
interaction between the juxtaposed side chains. For 3, the left-
handed (M) helix is stabilized by consecutively concatenated
9-, 10-, 11-, and 12-membered pseudorings in a repeating unit
(H9-12, Figure 2b). The amide orientations display the
desired pattern in all the structures.
Compounds 2, 3, 5, and 6 were synthetized on a solid
support and the purified products were characterized by RP-
HPLC, MS, and various NMR methods using different
solvents; namely 8 mm solutions each in CD3OH,
[D6]DMSO, and water (H2O/D2O 90:10). The NMR signal
dispersions were good for 2 and 3 and resonance broadening
was not observed. The resonance assignments were carried
out at 277 K, the temperature at which the best signal
resolutions were obtained. For 5 and 6, the signal dispersions
were poorer, especially in the CaH and CbH regions; this was
also the case at lower temperature, indicating the absence of
periodic secondary structures, therefore making the reso-
nance assignments only partially possible. The chemical shifts
of the backbone amide NH groups of 2 were measured for a
temperature gradient (Dd DT1) in [D6]DMSO, and they were
generally above5 ppbK1 (see Figure S5a in the Supporting
Information); the highest value was observed at the central
part of the sequence (3.86 ppbK1 for NH5) indicating
shielding from the solvent.[19–21] Sequence 5 displays a Dd
DT1 less than 5 ppbK1, which supports the structure
breaking effect of the disrupted stereochemical pattern. The
exception is NH4 wherein Dd DT1 increased in 5 as
compared with that of 2, which is attributed to the proximity
of the Lys side chain potentially acting as a H-bond acceptor
for NH4. For 3, strongly shielded amides were found (see
Figure S5b in the Supporting Information). The disrupted
stereochemical pattern in 6 resulted in lower Dd DT1 values
in the middle part of the sequence, indicating the presence of
impaired hydrogen bonds. However, strong hydrogen bonds
are observed for NH4 and NH10, which suggest a partially
ordered structure different from that of 3.
Table 2: Signs of dihedral angles ([y and f]) induced by the config-
urations of the backbone atoms.
Residue type Backbone configuration Structuring effect
a (S)-Ca [
a (R)-Ca [+
b (S)-Ca [
b (R)-Ca [+
b (S)-Cb ]
b (R)-Cb +]
Figure 1. The de novo designed b- and ab-peptide sequences based
on the y][f sign, stereochemical patterns, and their quasi-randomized
controls. The side chains are indicated by the single letter codes
(hS=homo-serine). The configurations are indicated in the CIP system
with Alkyl=methyl, X=undefined stereochemistry.
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Thorough evaluation of the ROESY spectra revealed a
number of ii+ 2 and ii+ 3 interactions for 2 and 3
(Table 3). For 5 and 6, mainly sequential and intra-residue
NOE data were found. Structures were refined by using
NOE-derived distance restraints[6e] and a hybrid MC/MD
conformational sampling. The cluster analysis of the 104
conformations revealed two conformational families for 2,
both exhibiting the overall H14–16 fold with equally low
energy and root-mean-square violations (RMSV= 0.003 
for the lowest energy structures). The difference between the
two clusters was the fraying C-terminal, which is because of
the hydrogen bonding between the terminal amide and the b-
h-Asp side chain. The NH–CbH and NH–CaH vicinal
couplings were uniformly greater than 8.5 Hz, in accord
with the helical conformation. For 3, a single conformational
family was found, corresponding to the H9–12 helix
(RMSV= 0.010  for the best structure). The NH–CbH
vicinal couplings measured for the b residues were greater
than 9.0 Hz, while the 3J(NH–CaH) values for the a residues
were around 7.5 Hz. These values are in line with the H9–12
helix geometry, which requires that the a residues attain a
smaller NH-CaH torsion than the b residues at the NH-CbH
dihedral. No consistent violations of the distance restraints
were observed and the NOE data predicted by the ten lowest
energy conformations were detected in the spectra.
In the absence of a sufficient number of long-range
restraints, the standard structure refinement was not possible
for 5 and 6. The single ii+ 3 NOE (NH9–CaH6) for 6 defines
a turn in the central segment, thereby leading to loop-like
overall geometry (see the Supporting Information).
Electronic circular dichroism (ECD) spectra were run at
room temperature and, for consistence with the NMR
analysis, at 277 K too; no significant difference in the ECD
values was found, except for the slightly increased intensities
for the Cotton effects detected for 2 and 3 (Figure 3). The
disrupted structure 5 exhibits an asymmetric low wavelength
Cotton effect having a sign opposite to that of 2. The
extensive change in the ECD fingerprint indicates that the
H14–16 helix is destroyed. For 6, the altered stereochemical
pattern caused a complete change in the ECD fingerprint
relative to 3. The inverted symmetric Cotton effect might be
attributed to the loop-like organization, which is supported by
the NMR and modeling results. The ECD curve recorded in
water furnished convincing evidence of the stability of the
H9-12 helix of 3, because the same features can be observed,
though with decreased intensities. The H14–16 helix of 2
partially retains its spectral features even in the aqueous
environment in which the hydrogen bonds are destroyed, but
the fall in the intensity is significant. 5 and 6 display either a
Figure 2. Helical conformations predicted by molecular modeling for 1
(a) and 3 (b).
Table 3: Number of resolved NOE interactions for the studied models.
Type of NOE 2 3 5 6
intra-residue 27 21 3 9
ii+1 19 16 7 9
ii+2 5 6 0 0
ii+3 4 5 0 1
Figure 3. ECD curves measured at room temperature in methanol
(thick curves) and water (thin curves). a) For 2 (solid) and 5 (dashes).
b) For 3 (solid) and 6 (dashes). Data were normalized to unit
chromophore.
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great intensity loss or a complete difference in the ECD
spectra in water, thereby corroborating the absence of the
stable long-range organization.
These results suggest that the homochiral and the alter-
nating heterochiral systems do not permit access to all
possible periodic secondary structures. Herein, the necessary
requirements for helix formation in peptidic sequences were
postulated and experimentally tested in terms of stereochem-
ical patterns. Similar to analogue computers, the absolute
configurations of each residue can serve as binary codes for
the basic instruction set in the assembly language of the
peptidic foldamer sequences. Notably, however, the proposed
methodology is based on a set of geometrical requirements of
the periodic secondary structure formation, but the design
method cannot handle all the conditions required for folding
in solution. Testing of the limitations of this promising
approach requires additional experimental and theoretical
analyses.
Experimental Section
Peptide synthesis: Peptide oligomers 2, 3, 5, and 6were synthetized by
a standard solid-phase technique, utilizing 9H-fluoren-9-ylmethoxy-
carbonyl (Fmoc) chemistry. The crude reaction mixture was purified
by RP-HPLC methods and the appropriate fractions were combined
and lyophilized (see the Supporting Information for details). The
peptides were characterized by analytical RP-HPLC analysis and
mass spectrometry. The measured molecular weights were as follows:
2 m/z [M+H]= 956.1, m/z [M+2H]2+= 478.6; 3 m/z [M+H]+=
1259.8, m/z [M+2H]2+= 630.5; 5 m/z [M+H]= 956.0, m/z
[M+2H]2+= 478.5; 6 m/z [M+H]+= 1259.9, m/z [M+2H]2+= 630.6.
NMR experiments: NMR measurements were performed on a
Bruker Avance III 600 MHz spectrometer having a triple resonance
2.5 mm capillary probe with z-gradient coil in different solvents; 8 mm
solutions each in CD3OH, [D6]DMSO and water (H2O:D2O 90:10) at
296.1 K, 277.1 K, and 273.1 K. The ROESY measurements were
performed using a WATERGATE solvent suppression scheme. For
the ROESY spinlock, 225 and 400 msmixing times were used, and the
number of scans taken was 64. The TOCSY measurements were
performed with homonuclear Hartman–Hahn transfer with the
MLEV17 sequence, with an 80 ms mixing time, and the number of
scans taken was 32. For all the 2D spectra 2 K time domain points and
512 increments were applied. The processing was carried out by using
a cosine-bell window function, single-zero filling, and automatic
baseline correction.
ECD experiments: CD spectra were measured on a Jasco J810
dichrograph at 298 K in a 0.02 cm cell and at 277 K in a 0.1 cm cell.
Eight spectra were accumulated for each sample. The baseline
spectrum recorded for the solvent only was subtracted from the raw
data. The concentrations of the sample solutions were 1 mm for the
0.02 cm cell and 5 mm for the 0.1 cm cell. The data were normalized
for the number of chromophores.
Modeling: Molecular mechanical simulations were carried out in
the Chemical Computing GroupsMolecular Operating Environment
(MOE). For the energy calculations, the MMFF94x force field was
used, without a cutoff for van der Waals and Coulomb interactions,
and the distance-dependent dielectric constant (er) was set to e= 1.8
(corresponds to CH3OH). The conformational sampling was carried
out by using the hybridMonte Carlo (MC)/molecular dynamics (MD)
simulation (as implemented in MOE) at 300 K with a random MC
sampling step after every 10 MD steps. The MC-MD was run with a
step size of 2 fs for 20 ns, and the conformations were saved after
every 1000 MD steps, which resulted in 104 structures. For the NMR
restrained simulation, the upper distance limits were calculated by
using the isolated spin pair approximation and classified by the
following standard method (strong: 2.5 , medium: 3.5 , and weak
5.0 ). The lower limit was set to 1.8 . Restraints were applied as a
flat-bottomed quadratic penalty term with a force constant of
5 kcal2. The final conformations were minimized to a gradient of
0.05 kcalmol1 and the minimization was applied in a cascade
manner, using the steepest-descent, conjugate gradient, and truncated
Newton algorithm. For the ab initio calculations, the optimizations
were carried out with the Gaussian03 program: first at the HF/3-21G
level, and then by using density-functional theory at the B3LYP/6-
311G** level with a default set-up. Optimizations were performed
with the Polarizable ContinuumModel (CH3OH) also at the B3LYP/
6-31G* level.
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